MannKind Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (303)

Latest Posts

About This Stock More About This Stock
Maxim Wanted Bigger Capital Raise, Downgrades MannKind To Hold
Article By: The Fly
Wednesday, November 1, 2017 3:02 PM EST
Maxim analyst Jason Kolbert downgraded MannKind to Hold from Buy saying he believes the company has less than two operating quarters of cash on hand.
In this article: MNKD
Read
MannKind Corporation Reports Annual Net Profit
Article By: KKD Healthcare Analytics
Thursday, March 30, 2017 12:32 PM EST
MannKind Corporation recently reported its financial results for the fourth quarter and full year. The company’s total revenue for the quarter stood at $12.4 million. Its net income for the quarter was reported at $54 million.
In this article: MNKD Also: SNY
Read
Most Active Stock Options For End Of Day March 7, 2017
Article By: The Options Insider
Tuesday, March 7, 2017 5:37 PM EST
The most active stock options for end of day Tuesday: GM, MNKD, MJN, BMY and JCP.
In this article: GM, MNKD, MJN, BMY, JCP
Read
MannKind Corporation Shares Slip Despite Lawsuit Dismissal
Article By: ValueWalk
Thursday, August 25, 2016 4:15 PM EST
MannKind shares edged lower by as much as 2.23% to 85 cents per share during regular trading hours on Thursday after the company announced that the class-action lawsuit filed against it had been dismissed.
In this article: MNKD
Read
Biotech's Week Ahead: MannKind Corporation, Allergan, Teva Pharmaceutical And Horizon Pharma
Article By: TipRanks
Sunday, May 8, 2016 6:40 PM EST
It’s an eventful week ahead for pharmaceutical companies MannKind Corporation, Allergan, Teva Pharmaceutical and Horizon Pharma PLC , as analysts are anticipating these companies’ quarterly reports and speculating on game-changing drugs.
In this article: AGN, MNKD, HZNP, TEVA
Read

PARTNER HEADLINES

Latest Tweets for $MNKD

No tweets yet!

$MNKD

MannKind Corporation: Why The Mealtime Insulin Market Will Expand Drastically
David Patterson 6/30/2017 7:09:05 PM

Good article on #MannKind ($MNKD). I agree that the #insulin market will continue to grow. Before investing in this space, it's important to better understand what insulin is, how it works, and why demand is growing: https://scribeschool.net/how-insulin-works.html

1 to 1 of 1 comments